AIG
BTAI icon

American International Group’s BioXcel Therapeutics BTAI Stock Holding History

American International Group’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-645
Closed -$29.1K – 410
2024
Q1 		$29.1K Buy
645
+15
+2% +$716 ﹤0.01% 2882
2023
Q4 		$29.7K Sell
630
-3
-0.5% -$167 ﹤0.01% 2917
2023
Q3 		$25.6K Buy
633
+56
+10% +$5.66K ﹤0.01% 2960
2023
Q2 		$61.5K Hold
577
– – ﹤0.01% 2828
2023
Q1 		$172K Buy
577
+12
+2% +$5.12K ﹤0.01% 2201
2022
Q4 		$194K Sell
565
-2
-0.4% -$484 ﹤0.01% 2142
2022
Q3 		$107K Buy
567
+8
+1% +$1.86K ﹤0.01% 2517
2022
Q2 		$118K Buy
559
+24
+4% +$5.05K ﹤0.01% 2495
2022
Q1 		$179K Sell
535
-38
-7% -$11K ﹤0.01% 2303
2021
Q4 		$186K Sell
573
-17
-3% -$7.29K ﹤0.01% 2415
2021
Q3 		$286K Buy
590
+55
+10% +$24.2K ﹤0.01% 2213
2021
Q2 		$249 Buy
535
+69
+15% +$37.6K ﹤0.01% 2366
2021
Q1 		$321 Buy
466
+2
+0.4% +$1.61K ﹤0.01% 2095
2020
Q4 		$343 Buy
464
+26
+6% +$20.3K ﹤0.01% 1973
2020
Q3 		$304K Buy
438
+33
+8% +$24.8K ﹤0.01% 1877
2020
Q2 		$343K Buy
405
+148
+58% +$96.5K ﹤0.01% 1791
2020
Q1 		$92K Sell
257
-15
-6% -$5.39K ﹤0.01% 2352
2019
Q4 		$63K Buy
272
+34
+14% +$3.42K ﹤0.01% 2819
2019
Q3 		$27K Sell
238
-2
-0.8% -$315 ﹤0.01% 2988
2019
Q2 		$42K Buy
+240
New +$40.7K ﹤0.01% 2982

Other funds holding BTAI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American International Group's BTAI Position: Q2 2024 in Review

American International Group sold out of BioXcel Therapeutics (BTAI) in Q2 2024, closing a stake of 645 shares — an estimated $29.1K sold.

American International Group first reported a position in BTAI in Q2 2019 and held it in 20 quarters. The position peaked at $343K in Q2 2020. 74 funds tracked by Wall St. Rank hold BTAI as of Q2 2024.

  • American International Group reported no remaining BioXcel Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 645 BioXcel Therapeutics shares in Q2 2024, an estimated $29.1K.
  • American International Group first reported a position in BioXcel Therapeutics in Q2 2019 and held it in 20 quarters.
  • American International Group's BioXcel Therapeutics position peaked at $343K in Q2 2020.
  • 74 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.